Biolase stock forecast.
31 dic 2019 ... ... forecast period. ... exercisable to 1,800,000 shares of BIOLASE Common Stock, with an exercise price of $10.00 per share of BIOLASE common stock.
The Biolase Inc (BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1,639% increase from the current price of $1.2506. The highest analyst price target is $42.41, and the lowest is $1.0934.Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.The Soligenix, Inc stock price fell by -25.53% on the last day (Friday, 1st Dec 2023) from $0.98 to $0.730. During the last trading day the stock fluctuated 25.14% from a day low at $0.711 to a day high of $0.89. The price has been going up and down for this period, and there has been a 80.56% gain for the last 2 weeks.The company reported ($5.19) earnings per share (EPS) for the quarter. The firm earned $0.67 million during the quarter. Ideanomics had a negative trailing twelve-month return on equity of 246.84% and a negative net margin of 931.66%.Shortly following the annual meeting, the Board of Directors exercised such discretion to effect a 1-for-25 reverse stock split that will become effective at 11:59 p.m. Eastern Time on April 28, 2022, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on April 29, 2022.
31 dic 2021 ... Biolase's $2.31 target price implies massive potential gains considering the stock is just 40 cents per share today. Those gains are likely to ...The Soligenix, Inc stock price fell by -25.53% on the last day (Friday, 1st Dec 2023) from $0.98 to $0.730. During the last trading day the stock fluctuated 25.14% from a day low at $0.711 to a day high of $0.89. The price has been going up and down for this period, and there has been a 80.56% gain for the last 2 weeks.
Stock Price Forecast. According to 38 stock analysts, the average 12-month stock price forecast for Microsoft stock is $392, which predicts an increase of 3.45%. The lowest target is $263 and the highest is $475. On average, analysts rate Microsoft stock as a strong buy.
BIOLASE, Inc. (BIOL) is a global leader in dental lasers, trading on NasdaqCM. The stock price, news, quote and history of BIOLASE, Inc. (BIOL) are available on Yahoo Finance. See the latest performance outlook, earnings date, dividend yield, research reports and more.The average BIOLASE stock forecast 2028 represents a -25.15% decrease from the last price of $1.14999997615814. For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72.Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...CBAK Energy Technology Inc () Stock Market info Recommendations: Buy or sell CBAK Energy Technology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the CBAK Energy Technology share forecasts, stock quote and buy / sell signals below.According to present data CBAK Energy Technology's CBAT shares and …
Nov 27, 2023 · CEO. Website. 1984. 190. John Beaver. https://www.biolase.com. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists ...
Change in Control Agreement, dated August 9, 2023 by and between Biolase, Inc. and Steven Sandor 08-10 Seventh Amendment to Restated Certificate of Incorporation 07-26 - 9 views BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023 07-26 - 6 views
Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebBiolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary. Shortly following the annual meeting, the Board of Directors exercised such discretion to effect a 1-for-25 reverse stock split that will become effective at 11:59 p.m. Eastern Time on April 28, 2022, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on April 29, 2022.Webhace 5 días ... BIOLASE Stock Down 4.3 %. BIOL stock opened at $1.10 on ... Audioboom Group (LON:BOOM) Stock Price Passes Below 200-Day Moving Average of $206.35 ...
The recent spike has left investors curious about Biolase's stock price forecast. Will it come down soon or keep rising and exit the penny stock zone? BOIL's stock outlook leans bullish right now ...The recent spike has left investors curious about Biolase's stock price forecast. Will it come down soon or keep rising and exit the penny stock zone? BOIL's stock outlook leans bullish right now ...BIOLASE Stock Earnings. The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next ... Stock Price Forecast. According to 33 stock analysts, the average 12-month stock price forecast for Apple stock is $197.09, which predicts an increase of 3.05%. The lowest target is $120 and the highest is $240. On average, analysts rate Apple stock as …Webhace 3 días ... The price of gold rose 1.1% to $2,080.80. —Kevin Costelloe. —. Nov. 30. HEALTHCARE. San Clemente-based ICU Medical Inc. (Nasdaq: ICUI) rose 4.8% ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Cybin Inc () Stock Market info Recommendations: Buy or sell Cybin stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cybin share forecasts, stock quote and buy / sell signals below.According to present data Cybin's CYBN shares and potentially its market environment have been in a bullish cycle in the …Web
The Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.US0909117022. BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to ...
Historical daily share price chart and data for Biolase since 1992 adjusted for splits and dividends. The latest closing stock price for Biolase as of November 29, 2023 is 1.11.. The all-time high Biolase stock closing price was 242675.52 on January 21, 2004.; The Biolase 52-week high stock price is 97.50, which is 8683.8% above the current share price.hace 3 días ... The price of gold rose 1.1% to $2,080.80. —Kevin Costelloe. —. Nov. 30. HEALTHCARE. San Clemente-based ICU Medical Inc. (Nasdaq: ICUI) rose 4.8% ...The Biolase stock price fell by -6.45% on the last day (Monday, 27th Nov 2023) from $1.24 to $1.16. During the last trading day the stock fluctuated 10.00% from a day low at $1.10 to a day high of $1.21. The price has been going up and down for this period, and there has been a 0.87% gain for the last 2 weeks.Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...BIOLASE Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 1.19. Negative dynamics for BIOLASE shares will prevail with possible volatility of 4.961%. Pessimistic target level: 1.17. Optimistic target level: 1.23.BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes. Experience the BIOLASE difference and discover the limitless potential of laser dentistry. Dentists.WebThe Theriva Biologics, Inc. stock price gained 5.10% on the last trading day (Friday, 17th Nov 2023), rising from $0.390 to $0.410. During the last trading day the stock fluctuated 15.38% from a day low at $0.390 to a day high of $0.450. The price has been going up and down for this period, and there has been a -6.43% loss for the last 2 weeks.The recent spike has left investors curious about Biolase's stock price forecast. Will it come down soon or keep rising and exit the penny stock zone? BOIL's stock outlook leans bullish right now ...When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Amazon Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.
28 mar 2023 ... ... outlook," "potential," "plan," "seek," and similar expressions and ... stock-based and other non-cash compensation, allowance for doubtful ...
Evelo Biosciences Inc. $0.40. EVLO 1.25% ; Vivos Therapeutics Inc. $19.90. VVOS 18.78% ; Femasys Inc. $0.93. FEMY 2.33% ; Histogen Inc. $0.33. HSTO 2.19% ; BIOLASE ...
hace 3 días ... $0.24. CEI 0.49%. BIOLASE Inc. $1.15. BIOL 5.50%. SINTX Technologies Inc. $0.38. SINT 7.85%. T2 Biosystems Inc. $3.90. TTOO 10.17%. Astra Space ...Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …WebBIOLASE Stock Forecast 23 Nov. Presumably, on 11/23/2023, the price of shares will be in the range of $1.42 - $1.48. A $0.07 range width can provide 4.64% volatility. The weighted average price of this range is at $1.44, which is $0.00 lower than the previous day's weighted average price.BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants PR Newswire - Wed Sep 13, 10:16PM CDT. /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors See BIOLASE, Inc. (BIOL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.WebThe Series H Convertible Preferred Stock has a term of two (2) years and is convertible at the option of the holder at any time into shares of BIOLASE common stock at a conversion price of $0.1398.Jul 26, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The 1-for-100 reverse stock split will reduce the number of outstanding shares of Company common stock from approximately 104 million shares to ...
Biolase logo. Biolase. BIOL. $1.67, 1.21%, USA. What is the market capitalization of a company? The market capitalization sometimes referred as Marketcap, ...BIOLASE Stock Forecast 28 Oct. Presumably, on 10/28/2023, the price of shares will be in the range of $1.60 - $1.66. A $0.06 range width can provide 3.89% volatility. The weighted average price of this range is at $1.62, which is $0.01 lower than the previous day's weighted average price.FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...The average BIOLASE stock forecast 2028 represents a -25.15% decrease from the last price of $1.14999997615814. For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72.Instagram:https://instagram. funnest cities in the uswhich quarters are worth more moneycrypto robotspacex going public But, as per the real definition, the highest-priced penny stock is $5. Choosing to invest in the best penny stocks under $1 is not tough if you ... Looking at the potential market of the share is one of the best ways to evaluate the value of a penny stock. Biolase is a medical device firm and business leader globally in producing and ...The Protalix BioTherapeutics Inc stock price gained 0.719% on the last trading day (Friday, 17th Nov 2023), rising from $1.39 to $1.40. During the last trading day the stock fluctuated 3.28% from a day low at $1.37 to a day high of $1.42. The price has been going up and down for this period, and there has been a -24.32% loss for the last 2 … stella jones inc.earnings google We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...Shares of BIOLASE (NASDAQ: BIOL), a company that specializes in dental lasers, was up 20% in pre-market trading after it was granted a reprieve by the Nasdaq stock exchange. flowalgo reviews 100.03%. Get the latest BIOLASE Inc (BIOL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Find the latest analyst research for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.